One in Three Indians May Be Affected by Allergic Rhinitis as Allergy and Gut Health Disorders Surge in Bengaluru: Dr. Kushal Banerjee

IMT News Desk
IMT News Desk
· 3 min read
Dr. Kushal Banerjee highlights that one in three Indians may be affected by allergic rhinitis; Bengaluru leads allergy & gut health surge.

The incidence of environmental allergies and gut health disorders is increasing at a rapid pace and continues to be a significant public health concern in Bengaluru and around the world, affecting quality of life, workplace productivity and overall well-being, according to Dr. Kushal Banerjee, a leading homeopathic physician and researcher.

Current estimates suggest that 20- 30% of Indians experience allergic rhinitis, with residents of metropolitan cities such as Bengaluru particularly vulnerable due to increased exposure to environmental allergens and pollutants.

Known for its rapid urban expansion, increasing vehicular emissions, year-round pollen exposure and extensive construction activity, Bengaluru presents a unique set of environmental triggers that can contribute to allergic and respiratory conditions. Healthcare experts note that changing climatic patterns, air pollution and evolving lifestyles are contributing to a growing prevalence of chronic allergic and gastrointestinal disorders among urban populations.

Studies have shown that approximately 55% of employees report active symptoms of allergic rhinitis, experiencing an average of 52.5 symptomatic days each year. Beyond common symptoms such as sneezing, nasal congestion and itchy eyes, persistent allergies can contribute to sleep disturbances, fatigue, impaired concentration and reduced workplace productivity. Given Bengaluru’s large professional workforce and fast-paced work environment, these conditions can significantly affect daily functioning and quality of life.

The burden of respiratory illness is equally significant. More than 34 million Indians are estimated to be living with asthma, making India one of the countries with the highest asthma burdens globally. Economic analyses estimate that asthma contributes to an annual burden of approximately INR 71 billion (USD 7 billion) through direct medical expenses and productivity losses. Research further indicates that allergic rhinitis-related ‘presenteeism’ can result in an average of 2.3 hours of reduced productivity during each workday.

Gut health disorders are also becoming increasingly prevalent in urban populations. Conditions including irritable bowel syndrome (IBS), Gastroesophageal Reflux Disease (GERD), Inflammatory Bowel Disease (IBD), Small Intestinal Bacterial Overgrowth (SIBO), lactose intolerance, chronic constipation and functional diarrhoea have been associated with reduced quality of life and have broader impacts on immune function, sleep and overall health. Experts suggest that factors such as stress, dietary changes, sedentary lifestyles and disrupted routines common in metropolitan settings may further influence gut health.

Commenting on these growing concerns, Dr. Kushal Banerjee said, “Environmental allergies and gut health disorders are no longer fringe health issues; they are affecting productivity, mental well-being, sleep quality and overall quality of life in significant ways. In rapidly growing urban centres like Bengaluru, environmental factors combined with lifestyle changes may contribute to an increased burden of these conditions. This highlights the urgent need for greater awareness, early intervention and healthcare approaches that focus on the individual needs of each patient.”

Dr. Banerjee further emphasised the importance of patient empowerment and evidence-informed healthcare decisions. He said, “Patients today are seeking treatment strategies that align with their personal values and long-term health goals. As healthcare providers, it is important to encourage informed decision-making, respect patient autonomy and continue supporting scientific inquiry across different therapeutic disciplines to improve patient outcomes.”

Read Next

India’s first focused health AI Conclave unites doctors and AI experts
Featured Article
July 10, 2026

India’s first focused health AI Conclave unites doctors and AI experts

• Global Healthcare Academy hosts HAI Conclave 2026, India’s first national platform dedicated to Healthcare and Artificial Intelligence • Landmark Bengaluru conference brings together healthcare leaders and AI experts to explore how Artificial Intelligence can make healthcare faster, safer and more accessible while keeping patients at the centre of every decision The inaugural edition of the HAI Conclave […]
Article by: IMT News Desk
Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026
News
July 10, 2026

Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026

Fischer Medical Ventures Limited (FMVL) has announced that its strategic partner, Nanyang Biologics, has achieved a major international milestone with its AI-powered molecular research platform, NYB.AI, being featured in the opening showcase at NVIDIA GTC Taiwan 2026, ahead of the keynote address by NVIDIA Founder and CEO Jensen Huang. The recognition places NYB.AI among a […]
Article by: IMT News Desk
Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs
News
July 10, 2026

Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs

Indian pharmaceutical companies are expected to report healthy revenue growth in the first quarter of FY27, but margins are likely to compress as sector profitability comes under pressure. In a recent preview note, Goldman Sachs said it anticipates around 185 basis points year-on-year margin decline for the sector in the June quarter, driven primarily by […]
Article by: IMT News Desk
Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue
News
July 10, 2026

Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue

Dr Reddy’s Laboratories has announced a delay in commercial supplies of its semaglutide product after certain batches were found to be out of specification due to an issue with the active pharmaceutical ingredient (API) used in the drug. The company said it has initiated an investigation into the root cause and is taking corrective measures […]
Article by: IMT News Desk